Dr Reddy S
- All
- News
- Videos
-
All About Andhra Pradesh's Ex Chief Minister Jagan Mohan Reddy, Involved In Feud With Sister
Jagan Reddy is the son of the late Dr YS Rajasekhara Reddy (YSR), two-time former Chief Minister of Andhra Pradesh.
-
Andhra Chief Minister Unveils World's Largest Statue Of BR Ambedkar
In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada.
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
-
Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.
-
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
-
Stocks To Watch: Zomato, Adani Enterprises, Infosys, Dr Reddy's
The domestic stock indices are likely to trade higher on Monday, taking cues from their global peers.
-
Dr Reddy's Plans 'Business Continuity' In Russia
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
-
Sensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top Drags
The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues.
-
Stocks To Watch: Airtel, Future Retail, GAIL India, Dr Reddy's
The domestic stock indices are likely to trade lower on Wednesday taking cues from the global markets.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
All About Andhra Pradesh's Ex Chief Minister Jagan Mohan Reddy, Involved In Feud With Sister
Jagan Reddy is the son of the late Dr YS Rajasekhara Reddy (YSR), two-time former Chief Minister of Andhra Pradesh.
-
Andhra Chief Minister Unveils World's Largest Statue Of BR Ambedkar
In a significant move towards promoting inclusivity and honouring the contributions of BR Ambedkar, Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Friday unveiled the statue of Dr BR Ambedkar in Vijayawada.
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
-
Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.
-
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
-
Stocks To Watch: Zomato, Adani Enterprises, Infosys, Dr Reddy's
The domestic stock indices are likely to trade higher on Monday, taking cues from their global peers.
-
Dr Reddy's Plans 'Business Continuity' In Russia
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
-
Sensex Tanks Over 700 Points, Nifty Trades Below 17,550; Tech Mahindra, Bajaj Finserv, Dr Reddy's Among Top Drags
The Indian equity benchmarks continued to plunge for the fourth straight session on Friday amid weak global cues.
-
Stocks To Watch: Airtel, Future Retail, GAIL India, Dr Reddy's
The domestic stock indices are likely to trade lower on Wednesday taking cues from the global markets.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
